...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR

It would be interesting to know how low Zenith is on cash flow and how many months till they run out of funds ?? As well what the plan is for financing the operations for the next 12 months,  If we are in quiet time as some have suggested what does mean ?  No more presenting at conference but spend the money to attend,??

If you want to attract attention the Zenith Epigenetics sceince platforms/tech you would think they should continue to present at as many conference as possible, ... Maybe they don't need anymore, but that would be silly unless there is very good reason to keep quiet.   speculating ???  i don't know 

Share
New Message
Please login to post a reply